
Medtronic PLC MDT
Quarterly report 2025-Q4
added 02-24-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.29 B |
Market Cap[1] |
$ 103 B |
EBITDA (LTM) |
$ 7.85 B |
P/E (LTM) |
21.42 |
P/S (LTM) |
2.99 |
EPS (LTM) |
3.78 |
Medtronic is an international medical company that specializes in developing and manufacturing innovative medical technologies. The company was founded in the United States in 1949 and today is a leader in the field of medical technology.
Medtronic offers a wide range of products and services in cardiology, endocrinology, neurology, orthopedics, surgery, and more. Among the company's products are implantable cardiac pacemakers, glucose meters, insulin infusion pumps, pain management systems, deep brain stimulation devices, and much more.
Medtronic is actively engaged in scientific research and development in the field of medicine. As a result, its products are the most effective and safe for patients. The company also provides training and consultations to doctors and medical personnel on the use of its products.
Medtronic has offices and representatives in more than 160 countries around the world, which allows it to provide maximum accessibility of its products and services to patients worldwide. Medtronic is a reliable partner for medical institutions and patients who need innovative solutions to maintain health and life.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
$ 13.17 | 0.46 % | $ 1.78 B | Nasdaq Capital Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Delcath Systems
DCTH
|
$ 10.8 | 4.05 % | $ 387 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 25.6 | -0.43 % | $ 216 M | NYSE American | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.47 | 4.52 % | $ 130 M | Nasdaq Global Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Helius Medical Technologies
HSDT
|
$ 2.12 | 3.92 % | $ 1.29 M | Nasdaq Capital Market | ||
|
Inspire Medical Systems
INSP
|
$ 56.7 | 1.0 % | $ 1.67 B | NYSE,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 61.0 | 1.5 % | $ 3.33 B | Nasdaq Global Select Market | ||
|
ClearPoint Neuro
CLPT
|
$ 11.37 | 1.7 % | $ 322 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.61 | 0.36 % | $ 38 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.03 | - | $ 17.4 M | Nasdaq Global Select Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.65 | 3.92 % | $ 367 M | Nasdaq Global Select Market,SPB | ||
|
Butterfly Network
BFLY
|
$ 5.4 | 12.97 % | $ 1.14 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Sintx Technologies
SINT
|
$ 2.41 | 14.22 % | $ 6.68 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 91.34 | 1.29 % | $ 12.4 B | NYSE,SPB | ||
|
TransMedics Group
TMDX
|
$ 100.01 | -0.77 % | $ 3.4 B | Nasdaq Global Market | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 36.8 | 0.38 % | $ 1.14 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 84.03 | -5.06 % | $ 2.92 B | NYSE,SPB | ||
|
Stryker Corporation
SYK
|
$ 294.73 | -6.47 % | $ 113 B | NYSE,SPB | ||
|
Edwards Lifesciences Corporation
EW
|
$ 83.98 | 0.57 % | $ 49.1 B | NYSE,SPB | ||
|
Tandem Diabetes Care
TNDM
|
$ 19.41 | -0.61 % | $ 1.32 B | Nasdaq Global Market,SPB | ||
|
LENSAR
LNSR
|
$ 5.61 | 7.27 % | $ 67.1 M | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.35 | 5.47 % | $ 54.9 M | Nasdaq Global Select Market | ||
|
MiMedx Group
MDXG
|
$ 3.68 | 9.52 % | $ 544 M | Nasdaq Global Select Market | ||
|
Myomo
MYO
|
$ 0.9 | 4.16 % | $ 37.7 M | NYSE American |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.